Allogeneic cytokine-induced killer (CIK) cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic cytokine-induced killer (CIK) cell therapy, covering 2017-02-10 to 2017-02-10. Get the full timeline:
Most recent: Clinical Trial Update: Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies [Phase 1, Phase 2]